NextCure (NXTC) Change in Accured Expenses (2018 - 2026)

NextCure's Change in Accured Expenses history runs 9 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 289.07% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at -$816000.0 (down 139.08% YoY), while the FY2025 annual figure was -$4.3 million, down 1405.42% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $4.7 million, up from $49000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $4.7 million in Q1 2026, with the low at -$5.2 million in Q2 2025.
• The 5-year median for Change in Accured Expenses is $105000.0 (2022), against an average of $98705.9.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses soared 415.96% in 2022, then plunged 755.14% in 2023.
• NextCure's Change in Accured Expenses stood at $105000.0 in 2022, then plunged by 674.29% to -$603000.0 in 2023, then jumped by 238.97% to $838000.0 in 2024, then sank by 94.15% to $49000.0 in 2025, then soared by 9563.27% to $4.7 million in 2026.
• Business Quant data shows NXTC's Change in Accured Expenses at $4.7 million in Q1 2026, $49000.0 in Q4 2025, and -$367000.0 in Q3 2025.